Skip to main content

ARGX · Argenx SE · Webcasts, Transcripts & Audio

827.0000 EUR 15-min delayed · Oct 7, 07:10 UTC

Argenx SE Webcasts

Earnings calls, investor updates, investor days and conferences for Argenx SE (ARGX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Conference
Investor event
2026-09-14
Argenx SE (ARGX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-08
Argenx SE (ARGX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-01
Argenx SE (ARGX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-23
Argenx SE (ARGX) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
Argenx SE (ARGX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Argenx SE (ARGX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Argenx SE (ARGX) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
Argenx SE (ARGX) Q4 2025 Earnings Call Transcript
Confident tone VYVGART franchise growth and patient reach MG label expansion (seronegative and ocular) CIDP momentum and label update
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Argenx SE (ARGX) Q3 2025 Earnings Call Transcript
Confident tone VYVGART commercial momentum Upcoming 2026 registrational readouts Pipeline expansion and Phase III assets
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Argenx SE (ARGX) Q2 2025 Earnings Call Transcript
Confident tone VYVGART commercial performance CIDP launch progress Indication breadth - myositis, Sjogren's, TED
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Argenx SE (ARGX) Q1 2025 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Argenx SE (ARGX) Q4 2024 Earnings Call Transcript
Confident tone VYVGART commercial momentum and launch execution Pipeline expansion and innovation engine Empasiprubart (C2 inhibitor) registrational strategy
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Argenx SE (ARGX) Q3 2024 Earnings Call Transcript
Confident tone CIDP launch (VYVGART Hytrulo) VYVGART commercial momentum (gMG) Pipeline and pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Argenx SE (ARGX) Q2 2024 Earnings Call Transcript
Confident tone CIDP launch Vision 2030 and long-term growth ambitions Clinical trial execution and inherent risks
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Argenx SE (ARGX) Q1 2024 Earnings Call Transcript
Confident tone VYVGART commercial growth Pre-filled syringe and label expansion Clinical pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Argenx SE (ARGX) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Argenx SE (ARGX) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Argenx SE (ARGX) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Argenx SE (ARGX) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Argenx SE (ARGX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Argenx SE (ARGX) Q2 2022 Earnings Call Transcript
Revenue
$96.00M
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Argenx SE (ARGX) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Argenx SE (ARGX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Argenx SE (ARGX) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Argenx SE (ARGX) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Argenx SE (ARGX) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Argenx SE (ARGX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Argenx SE (ARGX) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Argenx SE (ARGX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–29 of 29 webcasts